Observations indicate a marked decrease in Prox1 expression across several gastrointestinal tumors, like liver cancer and pancreatic cancer, with the degree of reduction correlating significantly with the differentiation status of the tumor (108–110). The gene discussed is PROX1; the disease is neoplasm.